Søren Brøgger Christensen

Søren Brøgger Christensen

Professor emeritus, Professor, emeritus

Member of:


    1. Published

      Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer

      Denmeade, S. R., Jakobsen, C. M., Janssen, S., Khan, S. R., Garrett, E. S., Lilja, H., Christensen, Søren Brøgger & Isaacs, J. T., 2 Jul 2003, In: National Cancer Institute. Journal (Online). 95, 13, p. 990-1000 11 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    2. Published

      Thapsigargin, origin, chemistry, structure-activity relationships and prodrug development.

      Doan, T. Q. N. & Christensen, Søren Brøgger, Oct 2015, In: Current Pharmaceutical Design. 21, 38, p. 5505-5517 13 p.

      Research output: Contribution to journalReviewResearchpeer-review

    3. Published

      Chemo- and regioselective functionalization of nortrilobolide: application for semi-synthesis of the natural product 2-acetoxytrilobolide

      Doan, T. Q. N., Crestey, F., Olsen, C. E. & Christensen, Søren Brøgger, 2015, In: Journal of Natural Products. 78, 6, p. 1406-1414

      Research output: Contribution to journalJournal articleResearchpeer-review

    4. Published

      Novel thapsigargin analogues and methods of preparing them

      Doan, T. Q. N., Christensen, Søren Brøgger & Crestey, F. L. J., 30 Dec 2015, Patent No. WO2015197860 A2, Priority date 27 Jun 2014, Priority No. DK20140070395 20140627

      Research output: Patent

    5. Published

      Antiplasmodial Constituents of Cajanus cajan

      Duker-Eshun, G., Jaroszewski, J. W., Asomaning, W. A., Oppong-Boachie, F. & Christensen, Søren Brøgger, 1 Feb 2004, In: Phytotherapy Research. 18, 2, p. 128-130 3 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    6. Published

      Targeting Toxins toward Tumors

      Franzyk, Henrik & Christensen, Søren Brøgger, 2021, In: Molecules. 26, 5, 23 p., 1292.

      Research output: Contribution to journalJournal articleResearchpeer-review

    7. Published

      Ca2+ influx in human T lymphocytes is induced independently of inositol phosphate production by mobilization of intracellular Ca2+ stores. A study with the Ca2+ endoplasmic reticulum‐ATPase inhibitor thapsigargin

      Gouy, H., Cefai, D., Christensen, Søren Brøgger, Debré, P. & Bismuth, G., Oct 1990, In: European Journal of Immunology. 20, 10, p. 2269-2275 7 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    8. Published

      Cyclic AMP- and inositol phosphate-independent inhibition of Ca2+ influx by cholera toxin in CDS-stimulated jurkat T cells: A study with a cholera toxin-resistant cell variant and the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin

      Gouy, H., Cefai, D., Christensen, Søren Brøgger, Debre, P. & Bismuth, G., 1 Aug 1991, In: Journal of Immunology. 147, 3, p. 757-766 10 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    9. Published

      Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells

      Griend, D. J. V., Antony, L., Dalrymple, S. L., Xu, Y., Christensen, Søren Brøgger, Denmeade, S. R. & Isaacs, J. T., 2009, In: Molecular Cancer Therapeutics. 8, 5, p. 1340-1349

      Research output: Contribution to journalJournal articleResearchpeer-review

    10. Published

      Thapsigargin-induced increase in cytoplasmic Ca2+concentration and aldosterone production in rat adrenal glomerulosa cells: Interaction with potassium and angiotensin-II

      Hajnóczky, G., Várnai, P., Holló, Z., Christensen, Søren Brøgger, Balla, T., Enyedi, P. & Spät, A., 1 May 1991, In: Endocrinology. 128, 5, p. 2639-2644 6 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    Previous 12 3 4 5 6 7 8 9 ...18 Next

    ID: 1300951